MedTrace Logo

Association of Anticholinergic Burden With Onset of Delirium in Older Adults With Alzheimer Dementia:

NCT05055895 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2021-09-24

No results posted yet for this study

Summary

Drugs with anticholinergic properties are commonly prescribed to older persons despite growing evidence of their significant adverse effects. However, limited data are available concerning their contribution to time of onset of delirium. This study aimed to determine the potential association of higher anticholinergic burden to early-onset of delirium superimposed dementia in the older adult.

Conditions

  • Delirium
  • Anticholinergic Adverse Reaction
  • Alzheimer Disease

Interventions

DRUG

Anticholinergic burden

The anticholinergic burden (ACB) was assessed using the Anticholinergic Burden Scale. Higher ACB was described as equal or higher than 1.

Sponsors & Collaborators

  • Gulhane Training and Research Hospital

    lead OTHER_GOV

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-01
Primary Completion
2021-06-30
Completion
2022-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05055895 on ClinicalTrials.gov